Locations
Frederiksberg, Denmark
industry
Biotech · Biotechnology · Biotechnology Research · Drug Development · Drug Discovery · Healthcare · Health Care · Oncology · Pharma · Science and Engineering
Size
51 - 200 employees
Stage
Other
founded in
2017
Adcendo is a Danish clinical-stage biotech company headquartered in Copenhagen, dedicated to the development of highly differentiated First-In-Class Antibody-drug conjugates (ADCs) for treatment of solid tumors. In November of 2024, the company announced the closing of a USD 135m series B financing round. With a total sum of USD 240m raised since 2021 and under the leadership of a highly experienced management team, Adcendo is moving forward a growing and highly differentiated pipeline of drug candidates into the clinic.
Something looks off?